PhRMA Strikes Back at HRSA’s 340B Orphan Drug Policy Announcement

by Admin | June 19, 2014 1:07 pm

June 19, 2014—The Health Resources and Services Administration acted “wholly at odds” with a federal district judge’s orders when it announced yesterday that it stands by its interpretation of the 340B orphan drug exclusion, brand-name drugmakers argued in papers filed with the judge late on June 18.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2014/06/phrma-strikes-back-at-hrsas-340b-orphan-drug-policy-announcement/

Copyright ©2024 340binformed.org unless otherwise noted.